-
Your next patient is a 17-year-old female, who says she is interested in using an oral contraceptive (OC) to help control her acne. How do you discuss the use of the Pill in her acne treatment?
-
With approval from the FDA and a recommendation from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) in hand, providers are poised to offer the first vaccine specifically designed to prevent cervical cancer.
-
The latest U.S. estimates show that some 1 million to 1.2 million people in the United States are living with HIV/AIDS, with 24-27% undiagnosed and unaware of their HIV infection.
-
Power up the radar when it comes to bacterial vaginosis (BV) and trichomoniasis. The first national data on the subject show high prevalence of both reproductive tract infections.
-
In the August 2006 article, "Study looks at weight impact on OC efficacy," the apparent conclusion that weight is not associated with differential pregnancy rates is not supported by the data presented.
-
The Food and Drug Administration (FDA) has just given approval to Seasonique (Duramed Pharmaceuticals; Pomona, NY), an extended-regimen oral contraceptive (OC).
-
Women who switch to the NuvaRing contraceptive vaginal ring (Organon, Roseland, NJ) from other forms of hormonal contraception experience reduced hormone-related adverse events, according to results from a study presented at the recent European Society of Contraception in Istanbul, Turkey.1
-
Your next patient is a 35-year-old mother of two who is experiencing ongoing heavy menstrual bleeding (menorrhagia). Recently remarried, she says she may want to have a child in the future with her new partner. What are your treatment options?
-
For years, the much talked-about male contraceptive pill has remained tantalizingly out of reach. What if the first contraceptive method to reach the commercial market relied on a nonhormonal approach instead?
-
When discussing spermicides with prospective users, family planning providers in the United States have only nonoxynol-9 (N-9) formulations in the contraception arsenal. What if there were other formulations added to the mix?
